Income Tax Expense (Benefit) in USD of GILEAD SCIENCES, INC. from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
GILEAD SCIENCES, INC. quarterly/annual Income Tax Expense (Benefit) history and change rate from Q1 2010 to Q3 2025.
  • GILEAD SCIENCES, INC. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $589M.
  • GILEAD SCIENCES, INC. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $1.78B, a 2765% increase year-over-year.
  • GILEAD SCIENCES, INC. annual Income Tax Expense (Benefit) for 2024 was $211M, a 83.1% decline from 2023.
  • GILEAD SCIENCES, INC. annual Income Tax Expense (Benefit) for 2023 was $1.25B, a 0.08% decline from 2022.
  • GILEAD SCIENCES, INC. annual Income Tax Expense (Benefit) for 2022 was $1.25B, a 39.9% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

GILEAD SCIENCES, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.78B $589M +$886M 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 $890M $468M +$30M +6.85% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $860M $334M +$649M 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $211M $385M +$149M +63.1% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 $62M -$297M -$443M -303% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 $505M $438M -$111M -20.2% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 $616M -$315M -$631M -200% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q4 2023 $1.25B $236M -$162M -40.7% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $1.41B $146M -$500M -77.4% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $1.91B $549M +$181M +49.2% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $1.73B $316M +$480M 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 $1.25B $398M +$15M +3.92% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025
Q3 2022 $1.23B $646M -$206M -24.2% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 $1.44B $368M +$68M +22.7% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 $1.37B -$164M -$706M -130% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q4 2021 $2.08B $383M +$113M +41.9% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2024
Q3 2021 $1.96B $852M +$380M +80.5% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $1.58B $300M -$73M -19.6% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 $1.66B $542M +$77M +16.6% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 $1.58B $270M +$1.06B 01 Oct 2020 31 Dec 2020 10-K 22 Feb 2023
Q3 2020 $522M $472M +$805M 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 -$283M $373M -$162M -30.3% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 -$121M $465M +$83M +21.7% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 -$204M -$788M -$1.8B -178% 01 Oct 2019 31 Dec 2019 10-K 23 Feb 2022
Q3 2019 $1.6B -$333M -$898M -159% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020
Q2 2019 $2.5B $535M +$268M +100% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 $2.23B $382M -$112M -22.7% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020
Q4 2018 $2.34B $1.01B -$4.95B -83% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021
Q3 2018 $7.29B $565M -$394M -41.1% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019
Q2 2018 $7.68B $267M -$779M -74.5% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019
Q1 2018 $8.46B $494M -$424M -46.2% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q4 2017 $8.89B $5.96B +$5.14B +626% 01 Oct 2017 31 Dec 2017 10-K 25 Feb 2020
Q3 2017 $3.74B $959M +$8M +0.84% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018
Q2 2017 $3.74B $1.05B +$144M +16% 01 Apr 2017 30 Jun 2017 10-Q 06 Aug 2018
Q1 2017 $3.59B $918M -$17M -1.82% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 $3.61B $821M +$69M +9.18% 01 Oct 2016 31 Dec 2016 10-K 26 Feb 2019
Q3 2016 $3.54B $951M +$71M +8.07% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017
Q2 2016 $3.47B $902M -$112M -11% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017
Q1 2016 $3.58B $935M +$28M +3.09% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 $3.55B $752M -$16M -2.08% 01 Oct 2015 31 Dec 2015 10-K 27 Feb 2018
Q3 2015 $3.57B $880M +$233M +36% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016
Q2 2015 $3.34B $1.01B +$358M +54.6% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016
Q1 2015 $2.98B $907M +$181M +24.9% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016
Q4 2014 $2.8B $768M +$442M +136% 01 Oct 2014 31 Dec 2014 10-K 27 Feb 2017
Q3 2014 $2.36B $647M +$353M +120% 01 Jul 2014 30 Sep 2014 10-Q 04 Nov 2015
Q2 2014 $2B $656M +$348M +113% 01 Apr 2014 30 Jun 2014 10-Q 05 Aug 2015
Q1 2014 $1.65B $726M +$504M +226% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015
Q4 2013 $1.15B $326M +$63M +23.9% 01 Oct 2013 31 Dec 2013 10-K 24 Feb 2016
Q3 2013 $1.09B $294M +$14.4M +5.15% 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2014
Q2 2013 $1.07B $308M +$44.5M +16.9% 01 Apr 2013 30 Jun 2013 10-Q 04 Aug 2014
Q1 2013 $1.03B $222M -$8.86M -3.83% 01 Jan 2013 31 Mar 2013 10-Q 07 May 2014
Q4 2012 $1.04B $263M +$106M +67.5% 01 Oct 2012 31 Dec 2012 10-K 25 Feb 2015
Q3 2012 $932M $280M +$42.6M +17.9% 01 Jul 2012 30 Sep 2012 10-Q 31 Oct 2013
Q2 2012 $889M $264M +$23.4M +9.74% 01 Apr 2012 30 Jun 2012 10-Q 01 Aug 2013
Q1 2012 $866M $231M +$4.02M +1.77% 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013
Q4 2011 $862M $157M -$16.1M -9.28% 01 Oct 2011 31 Dec 2011 10-K 25 Feb 2014
Q3 2011 $878M $237M -$21.4M -8.28% 01 Jul 2011 30 Sep 2011 10-Q 06 Nov 2012
Q2 2011 $899M $240M -$43.9M -15.5% 01 Apr 2011 30 Jun 2011 10-Q 01 Aug 2012
Q1 2011 $943M $227M -$80.5M -26.1% 01 Jan 2011 31 Mar 2011 10-Q 04 May 2012
Q4 2010 $1.02B $173M 01 Oct 2010 31 Dec 2010 10-K 27 Feb 2013
Q3 2010 $259M 01 Jul 2010 30 Sep 2010 10-Q 04 Nov 2011
Q2 2010 $284M 01 Apr 2010 30 Jun 2010 10-Q 05 Aug 2011
Q1 2010 $308M 01 Jan 2010 31 Mar 2010 10-Q 09 May 2011

GILEAD SCIENCES, INC. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $211M -$1.04B -83.1% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 $1.25B -$1M -0.08% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 $1.25B -$829M -39.9% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 $2.08B +$497M +31.5% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024
2020 $1.58B +$1.78B 01 Jan 2020 31 Dec 2020 10-K 22 Feb 2023
2019 -$204M -$2.54B -109% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022
2018 $2.34B -$6.55B -73.7% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 $8.89B +$5.28B +146% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020
2016 $3.61B +$56M +1.58% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019
2015 $3.55B +$756M +27% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018
2014 $2.8B +$1.65B +143% 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017
2013 $1.15B +$113M +10.9% 01 Jan 2013 31 Dec 2013 10-K 24 Feb 2016
2012 $1.04B +$176M +20.4% 01 Jan 2012 31 Dec 2012 10-K 25 Feb 2015
2011 $862M -$162M -15.8% 01 Jan 2011 31 Dec 2011 10-K 25 Feb 2014
2010 $1.02B 01 Jan 2010 31 Dec 2010 10-K 27 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.